PPARG rs310746: What Your Genotype Means
The rs310746 variant is a common genetic change located within the PPARG gene. Research has explored its potential association with a nominal increased risk for developing systemic sclerosis, a complex autoimmune condition.
What each genotype means
Typical systemic sclerosis risk
This genotype represents the common form of the PPARG gene variant. Research indicates that individuals with this genotype do not carry the specific allele associated with a nominal increase in systemic sclerosis susceptibility observed in some studies.
This is the most common genotype observed in most global populations.
Slightly elevated risk profile
Carrying one copy of the T allele has been associated in some research with a nominal increase in the risk of developing systemic sclerosis. This association is based on statistical trends in large cohorts and does not mean an individual will develop the condition.
This heterozygous genotype is found at varying frequencies across different ancestral groups.
Increased systemic sclerosis risk
Individuals with two copies of the T allele may have a higher statistical association with systemic sclerosis susceptibility compared to those without the variant. This finding is based on nominal associations in genetic studies and should be viewed as a small contributor to overall health risk.
This homozygous genotype is less common than the C/C or C/T genotypes in most studied populations.
Understanding the rs310746 Variant
The rs310746 variant is a single-nucleotide polymorphism (SNP) found within the PPARG gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant has been the subject of scientific investigation to determine if it influences biological pathways related to immune function or tissue regulation. Because it is located within a gene that plays a significant role in cellular metabolism and inflammation, researchers have hypothesized that variations here might contribute to disease susceptibility. It is important to note that rs310746 is just one of many variations in the human genome, and its presence does not determine health outcomes on its own. Genetic associations are typically complex, involving the interplay of many different genes, environmental factors, and lifestyle influences that collectively shape an individual's health profile over time.
The Role of the PPARG Gene
The PPARG gene provides instructions for making a protein called peroxisome proliferator-activated receptor gamma. This protein acts as a transcription factor, which means it helps control the activity of other genes by binding to specific regions of DNA. PPAR-gamma is primarily known for its role in regulating the storage of fatty acids and glucose metabolism, making it a key player in how the body manages energy. Beyond metabolism, this protein is also involved in regulating cell differentiation and has been shown to influence inflammatory responses. Because of these diverse functions, the PPARG gene is a frequent target of study in conditions involving chronic inflammation or metabolic dysfunction. By modulating the expression of various genes, the PPAR-gamma protein helps maintain cellular homeostasis, and researchers continue to investigate how variations in this gene might alter these critical regulatory processes.
Research and Evidence Strength
Scientific research into rs310746 has primarily focused on its potential link to systemic sclerosis (SSc), an autoimmune disease characterized by the hardening and tightening of the skin and connective tissues. Studies, including large-scale meta-analyses, have observed a nominal statistical association between this variant and SSc susceptibility. In these studies, the variant showed a modest odds ratio, suggesting a small increase in the statistical likelihood of the condition among those carrying the variant compared to those who do not. However, the evidence is considered moderate. While some studies have identified a trend or nominal association, these findings often do not reach the strict threshold of genome-wide significance required to confirm a definitive causal role. Consequently, the scientific community views this association as suggestive rather than conclusive, highlighting the need for further research to fully understand the biological mechanisms that might connect this specific genetic variant to systemic sclerosis.
Population Frequency and Interpretation
The rs310746 variant is considered common, meaning it is found frequently across various human populations. Because it is a common variant, many healthy individuals carry one or two copies of the associated alleles without ever developing systemic sclerosis. This is a crucial point for consumers: the presence of a common genetic variant is rarely sufficient to cause a disease on its own. Instead, it may contribute a very small amount to an individual's overall risk profile. When interpreting genetic information, it is essential to remember that statistical associations observed in large research cohorts do not translate directly into individual medical predictions. Most people with this variant will remain healthy, and the vast majority of systemic sclerosis cases are influenced by a wide array of genetic and non-genetic factors. Genetic data should be viewed as one small piece of a much larger, complex puzzle regarding human health.
What You Can Do With This Information
If you have received information about your rs310746 genotype, it is important to maintain a balanced perspective. This variant is associated with a nominal, non-definitive increase in risk for a specific condition, and it is not a diagnostic tool. You cannot use this information to predict whether you will develop systemic sclerosis or any other health issue. If you have concerns about your health, family history, or specific symptoms, the most effective step is to consult with a qualified healthcare professional or a genetic counselor. They can help you interpret your results in the context of your overall health and medical history. Avoid making medical decisions based solely on genetic reports. Always discuss any health-related questions with your doctor, who can provide personalized guidance based on clinical evidence rather than isolated genetic markers.
How common is this variant?
The rs310746 variant is common across diverse ancestral populations, with its specific genotypes appearing frequently in the general public.
Frequently asked questions
Does having the rs310746 variant mean I will get systemic sclerosis?
No. The association between this variant and systemic sclerosis is nominal and statistical, meaning it is observed in large groups but does not predict individual health outcomes. Most people with this variant do not develop the condition.
Is rs310746 a diagnostic test for autoimmune disease?
No, this variant is not used for clinical diagnosis. Genetic associations like this are for research purposes and do not provide the clinical certainty required for diagnosing medical conditions.
What should I do if my report shows I have this variant?
You do not need to take any specific medical action based on this result. If you have concerns about your health or family history, discuss them with your primary care physician or a genetic counselor.
Why is the evidence for this variant considered moderate?
The evidence is considered moderate because while some studies have shown a statistical association, these findings have not consistently reached the high level of significance required to establish a definitive cause-and-effect relationship.
Sources & further reading
Educational information only, last refreshed 10/28/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs310746?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in PPARG
The T allele of this PPARG variant is linked to favorable high-speed walking performance in elite athletic cohorts.
Variant in PPARG associated with differential glycemic and insulin sensitivity responses following aerobic exercise training.
This SNP is associated with variations in PPARG, a gene involved in glucose and lipid metabolism.
This variant is involved in insulin sensitivity and glucose metabolism pathways.
Influences sensitivity to dietary fat and risk for Type 2 Diabetes.
